Filing Flows › Comparisons › ENTA vs ASMB
Enanta Pharmaceuticals vs Assembly Biosciences: ENTA and ASMB compared
Enanta Pharmaceuticals is the larger company: $14.4M of revenue in its latest quarter (Q3 FY26) against $13.4M for Assembly Biosciences (Q2 2026). Assembly Biosciences is growing faster (+39% against -22% a year earlier). Assembly Biosciences is more profitable, with an operating margin of -47.4% against -120.0%.
Where the money goes: ENTA and ASMB
Enanta Pharmaceuticals (ENTA) · Q3 FY26
Enanta Pharmaceuticals, Q3 FY26: revenue $14.4M (-22% year over year), operating margin -120.0%, net loss $19.5M, operating cash flow −$10.0M. The chart follows the revenue to costs, profit and cash.
Assembly Biosciences (ASMB) · Q2 2026
Assembly Biosciences, Q2 2026: revenue $13.4M (+39% year over year), operating margin -47.4%, net loss $3.9M, operating cash flow −$15.5M. The chart follows the revenue to costs, profit and cash.
| Enanta Pharmaceuticals (ENTA) | Assembly Biosciences (ASMB) | |
|---|---|---|
| Latest quarter | Q3 FY26 | Q2 2026 |
| Revenue | $14.4M | $13.4M |
| Revenue growth, Y/Y | -22% | +39% |
| Operating margin | -120.0% | -47.4% |
| Net earnings | −$19.5M | −$3.9M |
| Net margin | -135.8% | -28.8% |
| Operating cash flow | −$10.0M | −$15.5M |
Questions
Which is bigger, Enanta Pharmaceuticals or Assembly Biosciences?
Enanta Pharmaceuticals is the larger company: $14.4M of revenue in its latest quarter (Q3 FY26) against $13.4M for Assembly Biosciences (Q2 2026).
Is Enanta Pharmaceuticals or Assembly Biosciences growing faster?
Assembly Biosciences is growing faster (+39% against -22% a year earlier).
Which is more profitable, Enanta Pharmaceuticals or Assembly Biosciences?
Assembly Biosciences is more profitable, with an operating margin of -47.4% against -120.0%.
More: Enanta Pharmaceuticals earnings · how Enanta Pharmaceuticals makes money · Assembly Biosciences earnings · how Assembly Biosciences makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Aug 12, 2026; 10-Q filed Aug 13, 2026). Fiscal quarters can end on different dates. Not investment advice.